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INTRODUCTION
Hepatocellular carcinoma with extension into the
right atrium has been regarded as beyond the realm
of surgical resection. Most patients have died within
a short period of pulmonary embolism, heart fail-
ure (1), or cancer progression.
In recent years, impressive progress has been
made in liver surgery, and with the development of
liver transplantation and the introduction of vascular
surgical techniques (2), successful surgery has been
performed for hepatic malignancies with tumor
thrombus to IVC and right atrium (3, 4). However,
appropriate indications and surgical procedures for
them are controversial. We report a patient with HCC
with tumor thrombus extending into the right atrium
through the middle hepatic vein and IVC. Using
cardiopulmonary bypass with total hepatic vascular
exclusion (THVE), we successfully performed a
left lobectomy with the simultaneous removal of
the tumor thrombus.
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Abstract: We report a successful liver resection using cardiopulmonary bypass with, total
hepatic vascular exclusion (THVE) for hepatocellular carcinoma (HCC), with extension into
the right atrium. A 61-year-old man with a cirrhotic liver was referred to our department
with HCC in the medial segment of the left lobe of the liver, and tumor thrombus ex-
tending into the right atrium. During surgery, a left lobe and caudate lobe of the liver
were transected leaving the left lobe of the liver connected to the inferior vena cava (IVC)
by only the left and middle hepatic trunks, and then the intracaval tumor thrombus and
the left lobe of the liver were removed en bloc using cardiopulmonary bypass with total
hepatic vascular exclusion (THVE). Cardiac arrest was not performed during THVE, and
the patient had an uneventful postoperative course and was discharged from the hospi-
tal 2 months following surgery. He died of multiple pulmonary metastases 4 years and 8
months after surgery ; however, imaging showed no evidence of recurrence in the rem-
nant liver during that period.
In conclusion, by performing dissection of the hepatic parenchyma to the hepatic vein
prior to removal of the tumor thrombus, the period of extracorporeal circulation, dura-
tion of warm ischemic time to the liver, and intraoperative blood loss were all reduced
and a radical operation could be performed safely without scattering tumor cells during
extirpation of the tumor. J. Med. Invest. 47 : 155-160, 2000
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Case report :
A 61-year-old man was referred to our department
on February 16, 1994, with the diagnosis of a liver
tumor which was detected on abdominal computed
tomography (CT) during a periodic medical exami-
nation for chronic HCV hepatitis. At physical exami-
nation on admission, the liver was palpable 4 cm
below the right costal margin with a firm consist-
ency and round border. There was no evidence of
ascites. Patient laboratory findings included a platelet
count of 13.0×104/mm3, serum bilirubin 0.6 mg/dl,
glutamic oxaloacetic transaminase (GOT) 50 IU/L,
glutamic pyruvic transaminase (GPT) 62 IU/L,
γ-glutamyl transpeptidase (γGTP) 65 IU/L, albumin
3.6 g/dl, prothrombin time (PT) 11.3 seconds, hepaplastin
test (HPT) 76.7%, retention rate of indocyanine
green 15 minutes after injection 8.7% (normal≦
10%), hepatitis B surface antigen (HBsAg) nega-
tive, hepatitis C virus antibody (HCV-Ab) positive,
α-fetoprotein (AFP) 3 ng/ml, and PIVKA-II (protein
induced by vitamin K absence of antagonist-II)
0.28 AU/ml (normal≦0.07 AU/ml). Contrast CT
showed a low-density mass with unclear borders
(3.0 cm in diameter) between the middle hepatic
vein (MHV) and left hepatic vein (LHV), which did
not enhance with contrast, and the tumor throm-
bus extending from the main tumor to the inferior
vena cava (IVC) (Fig. 1). In addition, a transesophageal
echocardiogram revealed that the tumor thrombus
extended into the right atrium (Fig. 2). On the basis
of these findings, a diagnosis of hepatocellular car-
cinoma in the medial segment of the left lobe of
the liver with growth into the right atrium was made.
Surgery was performed on March 21, 1994 using
cardiopulmonary bypass with total hepatic vascular
exclusion (THVE).
Bilateral subcostal incisions were made and, to
gain better exposure, a small upper midline incision
from the xyphoid process to the bilateral subcostal
incision was added (inverted Y-incision). No adhe-
sions, ascites or peritoneal dissemination were seen
in the peritoneal cavity. There were no suspicious
lymph nodes in the vicinity of the hepatoduodenal
ligament. The liver was firm with a micronodular
surface consistent with liver cirrhosis. The tumor
was located at the surface of the medial segment of
the left lobe of the liver. Intraoperative ultrasonography
revealed a well-defined hyperechoic mass (3.4×4.0 cm)
in the medial segment which was adherent to the
MHV near the confluence of the MHV and IVC.
There was no evidence of metastases or portal vein
thrombosis. Despite concern that a tumor fragment
might embolize distally, the hepatic parenchymal
resection was performed initially leaving the left lobe
connected by only the trunks of the MHV and LHV
because heparin would be used during extracorporeal
circulation.
After performing a cholecystectomy, the hepatoduodenal
ligament was dissected. The left hepatic artery, left
portal vein and left hepatic duct were ligated and
divided separately. The entire liver was mobilized from
its attachments. The suprahepatic and infrahepatic
IVC were exposed and taped. The tumor thrombus
was palpable in the suprahepatic IVC as an elastic,
hard, mass arising from the left lobe of the liver. A
demarcation line on the surface of the liver was
created. Transection of the liver parenchyma was
performed along this line with an ultrasonic scalpel
(Cavitron Ultrasonic Surgical Aspirator : CUSA).
The left lobe of the liver and the caudate lobe were
resected leaving the left lobe connected to the IVC
Fig. 1. Contrast computed tomography. A ill defined solitary
low density mass (arrow), approximately 3.0 cm in diameter was
found in the medial segment of the left lobe of the liver with a
filling defect extending into the IVC (arrow head).
Fig. 2. A transesophageal echocardiogram demonstrated a mass
indicating tumor thrombus (black arrow) in the right atrium.
RA : right atrium
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by only the common trunk of the MHV and LHV.
After obtaining hemostasis along the raw surface of
the liver, cardiovascular surgeons performed a me-
dian sternotomy. The pericardium and diaphragm
were divided at the level of the IVC hiatus in the
diaphragm. The superior vena cava (SVC), trunk of
the pulmonary artery, and the ascending aorta were
exposed and taped. Three catheters were inserted
into the SVC, IVC via the right femoral vein and the
ascending aorta. Heparin (0.3 mg/kg) was adminis-
tered intravenously. After satisfactory extracorporeal
cardiopulmonary bypass was established, THVE was
induced by clamping the SVC, the IVC just below
the liver, and the hilar tributaries (Pringle’s ma-
neuver) (Fig. 3). The trunk of the pulmonary artery
was also clamped to prevent the tumor thrombus
from embolizing distally. A longitudinal incision was
made in the center of the suprahepatic IVC from
the right atrium to the trunk of the MHV and LHV.
Then the common trunk was resected confluent
with the IVC. A left lobectomy with resection of the
caudate lobe and removal of the tumor thrombus
were performed en bloc.. Although a cardiac arrest
was not performed, bleeding from the IVC was easily
controlled with a pump sucker. The tumor throm-
bus was covered with a thin, fibrous membrane, and
there was no invasion into the wall of the right atrium
or IVC. The suprahepatic IVC was closed with a
running suture longitudinally. Heparin was neutral-
ized with protamine sulfate. After confirmation of a
normal activated clotting time (ACT), the extracorporeal
bypass was removed. Total bypass time and total
hepatic ischemic time were 25 minutes and 10 min-
utes, respectively. Operating time was 11 hours 22
minutes. Total blood loss during the operation was
2,910 ml. The resected specimen weighed 190 g.
The main tumor, 4.0×5.0 cm was located in the
medial segment of the left lobe of the liver and in-
vaded the MHV (Fig. 4). Histologically, the tumor
thrombus appeared to be partially covered with a
thin, fibrous endothelial membrane where it extended
into the IVC. Other regions of the tumor were ex-
posed to the blood. Microscopic findings showed
moderately differentiated HCC, trabecular type, with
Fig. 3. Cannulation for cardiopulmonary bypass
The superior vena cava, the pulmonary trunk, and the ascending aorta were exposed and taped. Two venous cathers were inserted
into the SVC and IVC via the right femoral vein, one arterial catheter was inserted into the ascending aorta. The pulmonary artery
was clamped to prevent air embolism, backflow of blood into the IVC and the tumor thrombus from embolizing distally during extra
corporeal circulation without cardiac arrest.
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capsule formation and liver cirrhosis.
The patient recovered uneventfully. He was dis-
charged from the hospital after a prophylactic hepatic
arterial injection of styrene maleic acid neocarzinostatin
(SMANCS, 3 mg). Unfortunately, multiple lung metas-
tases in both lungs were recognized in follow-up
chest radiography in June, 1995. However, the pa-
tient obtained only a partial response (PR) from the
administration of Carboplatin (CBDCA) intravenous-
ly and 5’-dexy-5-fluorouridine (5’-DFUR) orally. Al-
though the patient had a cancer bearing condition,
his dialy life was without restrictions.
In August, 1996, 2 years and 5 months after sur-
gery, the patient experienced hemoptysis due to a
metastatic lesion in the hilum of the left lung that
increased and invaded the bronchus directly. Radio-
therapy (total dose 50 Gy) was administered for this
lesion. Afterwards, he was administered CBDCA
(50 mg) intraveneously once a week in the out-patients
clinic, and the right lung metastatic lesions disap-
peared. However, that of the left lung gradually in-
creased, and he experienced hemoptysis again. The
patient died of cancer in November, 1998 (4 years
and 8 months after initial surgery). However, there
was no evidence of tumor in the remnant liver on
computed tomography (CT), ultrasonography (US)
or magnetic resonance imaging (MRI) during that
period.
DISCUSSION
Tumor extension into the right atrium in HCC is
rare. The incidence is reported as 0.6% in autopsy
cases (5). However, HCC with tumor invasion into
the IVC is reported to occur in 2.9% of patients by
imaging techniques, 0.7% at operation, and 18.2% at
autopsy in Japan (6). Since most of these patients
have accompanying intrahepatic metastases or dis-
tant metastases, they have been deemed to be be-
yond conventional surgical resection. Liver trans-
plantation is also contraindicated for such patients
(7) ; therefore, extended surgery such as total he-
patic vascular exclusion (THVE) using various bypasses
has been introduced to treat patients with advanced
tumors (2). However, these methods including a
“bench procedure” have yet to be established, and
many issues must be resolved including (8) : 1) in-
dications, 2) the hepatic tolerance to liver ischemia
of THVE, especially in the impaired liver, 3) surgi-
cal technique, 4) hemodynamic and metabolic con-
sequences of THVE, and 5) tumor recurrence fol-
lowing surgery.
With regard to the indications for extended sur-
gery, Pichlmayr et al . (9) have reported that these
approaches are necessary only in selected patients
and defined three categories of indications for the
“bench procedure” : 1) preferable, 2) optional, and
3) necessary. The present patient was classified in
category 3 due to conventional unresectability and
contraindications for liver transplantation. Further-
more, the right atrial tumor may obstruct the orifice
of the tricuspid valve with resultant sudden cardiac
death (ball valve syndrome) (1). Goth et al. reported
a patient with acute cardiac insufficiency treated
successfully by operative removal of a tumor throm-
bus (10). Nimura et al . also reported a patient who
survived 4 years following surgery (11). Accord-
ingly, patients with advanced HCC extending into
the right atrium may be candidates for surgery in the
emergency or elective setting. The present patient
had good hepatic reserve function (Child-Pugh A
classification). The main tumor lay within the medial
segment of the left lobe of the liver, and intrahepatic
or distant metastases were not evident. Therefore,
this suggest this patient was a good candidate for
surgery.
Technically, it is important for surgeons to confirm
the degree of tumor thrombus extension. If tumor
thrombus does not invade the IVC or right atrium,
it may be possible to remove thrombus via the right
atrium using conventional THVE by clamping the
IVC just below the right atrium (11). However, when
thrombus protrudes into the right atrium, it is neces-
sary to use cardiopulmonary bypass. Transesophageal
echocardiography is one of the most useful diag-
nostic tools in this setting. Chua et al. (12) advocated
performing an echocardiographic examination by
virtue of its versatility, safety and reliability in di-
agnosis of right atrial masses.
Fig. 4. Surgically resected specimen (posterior view). Tumor
thrombus (white arrow) had extended from the main tumor via
the middle hepatic vein.
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In 1987, Shimamura et al. (13) reported on two ex-
tremely instructive patients. In one patient, bleeding
could not be controlled from the raw surface of the
liver, and therefore removal of the tumor throm-
bus was performed using cardiopulmonary bypass
with heparin prior to hepatectomy. The other patient
had poor hemodynamic tolerance during THVEwith-
out bypass which led to incomplete removal of the
tumor thrombus. Therefore, it was suggested that
hepatectomy should be given priority over remov-
al of the tumor thrombus. This method allows for
control of bleeding from the raw surface of the liver
prior to the administration of heparin and a radical
operation may be performed without scattering tumor
cells during extirpation of the tumor. One disad-
vantage of the present procedure is that no means
could be taken to prevent distal embolization of the
tumor thrombus during hepatectomy. However, the
resected specimen showed that the tumor throm-
bus was covered with a thin, fibrous membrane and
endothelium. Therefore, as long as these maneuvers
are carefully performed, the tumor thrombi will
seldom embolize distally during hepatectomy. Onitsuka
et al. (14) reported a patient in whom removal of
intracardiac tumor was performed prior to hepatectomy.
By neutralizing heparin with protamine sulfate,
bleeding from the raw surface of the liver was effec-
tively controlled. However, during extirpation of the
tumor thrombus, significant bleeding from the IVC
prevented the complete removal of the tumor throm-
bus. With removal of the tumor thrombus prior to
hepatectomy, bleeding from the IVC via the lumbar
veins, phrenic veins, right adrenal vein and coro-
nary vein may be a significant problem. With THVE,
only clamping of the infrahepatic IVC just above the
renal veins caused some bleeding (15) andmade com-
plete removal of tumor thrombus difficult. Houguet
et al . (8) also noted that the effectiveness of THVE
was strictly related to proper surgical technique.
We performed complete THVE with dissection
of the posterior aspect of the retrohepatic IVC. After
the tumor thrombus had been removed from the IVC
and right atrium with the left lobe of the liver, the
clamp of the portal triad at the hilum (Pringle’s ma-
neuver) was released, and the IVC was sutured.
Bleeding from the IVC was well controlled with one
pump sucker to examine the inside of the IVC suf-
ficiently and shorten the period of warm liver ischemic
time. Yamaoka et al . (16) have emphasized the im-
portance of a period of warm liver ischemia with a
time of less than 60 minutes under venoveous bypass
in cirrhotic patients. Houguet et al. (17) applied THVE
to major hepatic resection in patients with normal
liver function for 38±5 minutes without any obvious
detrimental effects. By performing dissection of the
hepatic parenchyma prior to removal of the tumor
thrombus, the period of extracorporeal circulation,
duration of warm ischemic time and intraoperative
blood loss were all reduced. Accordingly, removal of
tumor thrombus prior to hepatic resection is only
necessary in patients with cardiac insufficiency re-
quiring emergency surgery.
Another technical consideration is whether cardiac
arrest is necessary. We were able to remove the
tumor thrombus with a beating heart. However, in
patients with the tumor thrombus invading the wall
of the right atrium or with extension into the right
ventricle, removal of the tumor thrombus should
be carried out with cardiac arrest.
Surgery is the only therapeutic modality for HCC
with invasion of the IVC and/or right atrium. There-
fore, every attempt should be made to establish an
operative method that allows for surgical resection
of HCC in an effort to prevent recurrence.
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